Beijing Key Lab for Immune-Mediated Inflammatory Diseases, Institute of Clinical Medical Sciences, China-Japan Friendship Hospital, Beijing 100029, China.
Heilongjiang Academy of Chinese Medical Sciences, Harbin 150001, China.
Biomed Res Int. 2021 May 15;2021:6667791. doi: 10.1155/2021/6667791. eCollection 2021.
Renal interstitial fibrosis (RIF) is the main pathological manifestation of end-stage renal disease. Recent studies have shown that endoplasmic reticulum (ER) stress is involved in the pathogenesis and development of RIF. Traditional Chinese medicine (TCM), as an effective treatment for kidney diseases, can improve kidney damage by affecting the apoptotic signaling pathway mediated by ER stress. This article reviews the apoptotic pathways mediated by ER stress, including the three major signaling pathways of unfolded protein response, the main functions of the transcription factor C/EBP homologous protein. We also present current research on TCM treatment of RIF, focusing on medicines that regulate ER stress. A new understanding of using TCM to treat kidney disease by regulating ER stress will promote clinical application of Chinese medicine and discovery of new drugs for the treatment of RIF.
肾间质纤维化(RIF)是终末期肾病的主要病理表现。最近的研究表明,内质网(ER)应激参与了 RIF 的发病机制和发展。中药(TCM)作为治疗肾脏疾病的有效方法,可以通过影响 ER 应激介导的细胞凋亡信号通路来改善肾脏损伤。本文综述了 ER 应激介导的凋亡途径,包括未折叠蛋白反应的三条主要信号通路、转录因子 C/EBP 同源蛋白的主要功能。我们还介绍了 TCM 治疗 RIF 的当前研究,重点介绍了调节 ER 应激的药物。通过调节 ER 应激来用 TCM 治疗肾脏疾病的新认识将促进中药的临床应用和治疗 RIF 的新药的发现。